Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation and provides skin protection. It is ubiquitously distributed in human tissues where it is transported in serum generally in association with very low density lipoproteins. Squalene is investigated as an adjunctive cancer therapy.
Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation and provides skin protection. It is ubiquitously distributed in human tissues where it is transported in serum generally in association with very low density lipoproteins. Squalene is investigated as an adjunctive cancer therapy.
临床用于促进造血功能恢复,提高外周血中白细胞数量。还用于各种缺氧性疾病、心脏病、肝炎、癌症的防治。
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H33021879 | 胶囊剂 | N/A | 0.25g | Chemical Drug | Approved | 2020/04/01 | Domestic | ||
国药准字H44024657 | 软胶囊剂 | N/A | 0.25g | Chemical Drug | Approved | 2024/04/26 | Domestic | ||
国药准字H51023900 | 胶囊剂 | N/A | 0.25g | Chemical Drug | Approved | 2021/03/15 | Domestic | ||
国药准字H32026379 | 胶囊剂(软胶囊) | N/A | 0.25g | Chemical Drug | Approved | 2020/07/30 | Domestic | ||
国药准字H44024670 | 胶囊剂(软胶囊) | N/A | 0.25g | Chemical Drug | Approved | 2015/05/28 | Domestic | ||
国药准字H20046462 | 胶囊剂(软胶囊) | N/A | 0.5g | Chemical Drug | Approved | 2015/06/02 | Domestic | ||
国药准字H44024679 | 胶囊剂 | N/A | 0.25g | Chemical Drug | Approved | 2020/02/20 | Domestic | ||
国药准字H20058371 | 胶囊剂 | N/A | 0.25g | Chemical Drug | Approved | 2021/07/14 | Domestic | ||
国药准字H44024658 | 胶囊剂(软胶囊) | N/A | 0.5g | Chemical Drug | Approved | 2024/04/26 | Domestic | ||
国药准字H23023064 | 胶囊剂 | N/A | 0.25g | Chemical Drug | Approved | 2015/09/25 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
160469 | Active | 2009/03/26 | squalene | ||
72121 | Active | 1999/11/30 | squalene | ||
51286 | Forest Pharmatech Pty Limited | Active | 1995/01/05 | squalene | |
192163 | Active | 2011/11/17 | squalene | ||
123331 | H & H International Technology Pty Ltd | Active | 2005/11/03 | squalene | |
323161 | Active | 2019/09/13 | squalene | ||
63685 | Active | 1998/03/26 | squalene | ||
97806 | Kelbra Holdings Pty Ltd | Active | 2003/10/28 | squalene | |
449367 | Active | 2024/05/22 | squalene | ||
122912 | Active | 2005/10/19 | squalene |